Constrictive bronchiolitis obliterans is a fibrotic disease of small airways characterized by progressive obliteration of the airway lumen, with resulting obstructive pulmonary physiology. While previous work has demonstrated the collagenous nature of the constrictive fi brotic lesions, elastin expression in the disease has been poorly characterized. Elastin is a critical component of the pulmonary extracellular matrix, and is responsible for the reversible deformability characteristic of the alveoli, pulmonary blood vessels, and airways. Elastin is a long-lived protein with virtually no active protein production occurring after lung development is completed during early childhood. We report a novel case of cryptogenic bronchiolitis obliterans in which elastin gene expression is actively upregulated in affected airways, and accompanied by myofi broblast hyperplasia and disorganized elastic fi ber deposition. In addition, deposition of new elastic fi bers by myofi broblasts is noted in the alveoli surrounding the affected bronchioles.
Introduction
Constrictive bronchiolitis obliterans (CBO) is a fi brotic lung disease primarily affecting the small (Յ3 mm diameter) conducting airways of the lungs (Couture and Colby 2003) . "Constrictive" bronchiolitis obliterans was fi rst used as a descriptive term in 1973 (Gosink et al 1973) , and describes a fi brosing infl ammatory process that surrounds, rather than fi lls, the airway lumen (Colby 1998) . This process results in extrinsic airway compression and luminal obliteration. CBO is rare in adults, and has been poorly studied. In most cases, the etiologic agent associated with CBO is known, although the evidence underlying some of these associations is tenuous (Ryu et al 2003) . The term "cryptogenic obliterative bronchiolitis" was fi rst used in 1981 to characterize cases of otherwise unexplained progressive airfl ow obstruction (Turton et al 1981) . A small number of pathologically confi rmed cryptogenic cases of CBO have however been documented (Kraft et al 1993) .
The bronchioles are a physiologically silent area of the lung as a result of their considerable cross-sectional area. The diameter of each successive distal airway generation decreases progressively from the tracheal division onward. However, the resulting total cross-sectional luminal area increases with each successive airway generation, a feature that attains the most signifi cance in the conducting airways distal to the origin of the bronchioles (Baraldo et al 2003) . Thus, extensive damage to the bronchioles may result in considerable pathophysiologic consequences. In CBO, where progressive obliteration of bronchioles leads to decreased conducting airway cross-sectional area, concomitant obstructive physiology develops that is complicated by air-trapping and hyperinfl ation.
Elastic fi bers are composite structures containing two primary morphologically distinguishable components, elastin and microfi brils (reviewed in Kielty et al (2002) ). Elastin, a major elastic fi ber component, is known to be essential for lung development and mechanical function (Mariani et al 1997) , and elastic fi bers are distributed throughout the lung, including the alveoli, airways, vessels and pleura. The rate of lung elastin synthesis is greatest during fetal and neonatal development, but is almost undetectable in healthy adult lung (Mariani et al 2002) . However, in pathological circumstances such as emphysema or pulmonary fi brosis, there may be reactivation of elastin expression in the adult lung leading to excessive or aberrant elastin deposition (Snider et al 1991; Lucey et al 1998; Hoff et al 1999) . Functional fi ber formation requires coordinated re-expression of all fi ber components in a temporally and spatially regulated sequence. This is assumed to be an ineffi cient process in adult tissue, as re-initiated elastin deposition in injured adult tissues is often characterized by faulty organization of the newly formed three-dimensional fi ber.
CBO predominantly affects small airways, with few or no histologic changes observed in the alveoli surrounding the diseased airways (Couture and Colby 2003) . Given that CBO involves both airway injury and a fi brotic response, the fi nding of increased production of extracellular matrix components in the airways would not be surprising. While previous work has confi rmed the presence of extensive collagenous fibrosis in the walls of bronchi with CBO (Markopoulo et al 2002) , elastin gene expression and protein deposition have been poorly characterized. Here, we report a case of cryptogenic bronchiolitis obliterans in which elastin expression and deposition are markedly and pathologically increased, not only in the affected bronchioles, but also in the surrounding alveoli.
Case report
A 63-year-old man with a 5-month history of progressive dyspnea, cough, and scant sputum production was referred for pulmonary evaluation. Prior to the onset of dyspnea he was fully functional without exercise limitation. Onset of his symptomatology was coincident with the development of an upper respiratory infection. Outpatient therapy with antibiotics and bronchodilators had resulted in a minimal but temporary improvement. At presentation, the patient was dyspneic with showering and climbing any stairs. Social history was remarkable for a 5-year history of cigar smoking, which he discontinued 25-years prior to referral. Extensive questioning did not yield any signifi cant history of occupational or environmental exposures, and family history was non-contributory for pulmonary disease. The patient had a history of a thymoma, but testing revealed no evidence of myasthenia gravis or any other systemic manifestations of thymic disease. CXR was signifi cant for bilateral hyperinfl ation, without evidence of emphysema. CT scan again demonstrated marked hyperinfl ation with little evidence to suggest emphysema. Bilateral bronchiectasis and bronchiolitis with lower lobe predominance were evident. Extensive workup for causes of secondary bronchiectasis was unremarkable. Spirometry confi rmed a partially reversible severe obstructive ventilatory defect, with an FEV 1 = 0.67L (19% predicted) an FVC = 2.17L (48% predicted), and an FEV 1 : FVC ratio of 39%. Lung volumes revealed no hyperinfl ation with a TLC = 7.84L (109% predicted), but air trapping was signifi cant with an RV = 5.28L (222% predicted). Resting ABG showed pH = 7.38, PaCO 2 = 54, and PaO 2 = 50 on room air, with a room-air SpO 2 of 88%. Six-minute walk testing demonstrated that the patient required supplemental oxygen at 2 L/min at rest and 3 L/min with activity to maintain an SpO 2 Ն 90%. Despite aggressive therapy with oxygen, bronchodilators, intermittent antibiotics, anti-infl ammatories (corticosteroids and macrolides), and rehabilitation, his disease continued to progress. Due to his severe clinical and physiologic impairments the patient was evaluated and listed for lung transplantation. Bilateral sequential lung transplantation was performed 3-months later without complication. At the time of surgery, the lungs were noted to be grossly hyperinfl ated, and did not defl ate after resection and removal from the thorax. An explant wedge biopsy sent for pathologic examination revealed the diagnosis of constrictive bronchiolitis obliterans, which on the basis of his clinical history was considered cryptogenic in etiology. The rest of the lung was placed in storage at −80 °C for further study. At the time of writing, the patient continues to do well Ͼ15 months after transplantation.
Methods and materials Lung processing
The explanted diseased lung was kept on ice during sampling, as was a donor lung rejected for transplantation that was used as a tissue control. Portions of peripheral lung 1 cm 2 were excised with a scalpel and fi xed without infl ation in 4% paraformaldehyde overnight at 4 °C before paraffi n embedding. Serial 5 μm-thick sections were cut, deparaffi nized, and stained with hematoxylin and eosin (H and E). Identical sections were used for Hart's staining, in-situ hybridization and immunohistologic staining.
Hart's elastin staining
Peripheral CBO and control lung tissue sections (5 μm) embedded in paraffi n were deparaffi nized and re-hydrated through graded ethanol to PBS, then soaked in 0.25% potassium permanganate solution for 5 minutes. Slides were cleared in 5% oxalic acid and soaked in resorcin-fuchsin solution (Poly Scientifi c, Bay Shore, NY, USA) overnight. After washing in water, sections were counterstained with tartrazine (yellow), dehydrated through graded ethanol, cleared in xylene and mounted.
Smooth muscle actin immunohistochemistry
Sections of paraffi n embedded peripheral CBO and control lung were deparaffi nized in xylene, then re-hydrated in a descending ethanol series and allowed to stand in PBS for 10 minutes. Slides were blocked for 1 hour with 10% fetal horse serum, rinsed in PBS, then incubated overnight at 4 ºC with the primary alpha smooth muscle actin (α-SMA) antibody (1A4 mouse monoclonal, 1:200 dilution, Sigma, St. Louis, MO, USA). After rinsing in PBS, sections were incubated in the dark with secondary antibody (fl uorescein-conjugated goat anti-mouse IgG, 1:250 dilution, 1 hour, room temperature, Jackson ImmunoResearch, Westgrove, PA). Following rinsing in PBS, sections were cover slipped using Vectashield mounting medium (Vector Laboratories, Burlingame, CA) and viewed under fl uorescent light for image capture.
In situ hybridization
Digoxygenin-labeled antisense and sense riboprobes were generated from a baboon tropoelastin cDNA that had been linearized for in vitro transcription (Promega, Madison, WI, USA). Sections of paraffi n embedded peripheral CBO and control lung were deparaffi nized, re-hydrated and digested with proteinase K. The tissue sections were blocked with triethanolamine and acetic anhydride, then hybridized with denatured digoxygenin-labeled riboprobe overnight at 60 °C. Following hybridizations, tissue sections were subjected to a series of washes including digestion with RNase A, treated with blocking agents, and incubated with an antibody conjugated to alkaline phosphatase. After additional washes, slides were incubated with a chromogen substrate for 1-3 days. After color development, specimens were counterstained with nuclear fast red.
Results

Initial analysis of the CBO lung
The explanted lung remained infl ated after resection and was fi rm to the touch. When tissue specimens of approximately 1 cm 3 were cut from the periphery of the lung, these too remained infl ated. Gross examination showed no obvious emphysematous changes within peripheral tissue sections. Staining with hematoxylin and eosin (H and E) showed that the peripheral tissue had few bronchioles, but no evidence of emphysema, confi rming the CXR, CT and formal pathologic fi ndings. Infl ammatory infi ltrates were present adjacent to large airways paralleling intralobar arteries. Some particulate deposits were associated with the infl ammatory infi ltrates (Figure 1, arrowheads) .
Excess elastic fi ber deposition and mRNA expression
Because the lung exhibited unusual mechanical properties, did not defl ate, and had no evidence of emphysematous changes, we next examined elastic fi bers by staining with Hart's elastin stain (Figure 1 , A′ and B′). Assessing and representing the integrity of elastic fi bers in single sections is exceptionally diffi cult. Nonetheless, extensive analysis of a large number of sections revealed a high density of elastic fi bers with a disorganized appearance, embedded within the tissue. Many of the elastic fi bers displayed a fractured appearance (as represented in Figure 1 , B′). To determine whether elastin synthesis was ongoing despite the accumulation of elastic fi bers in the tissue, we performed in situ hybridization for elastin mRNA on serial sections of tissue (Figure 1 , A′′ and B′′). This showed that elastin expression is active, and localizes to the walls of intralobar arteries, conducting airways, and terminal airways and alveoli adjacent to the infl ammatory infi ltrates. Within an infl ammatory infi ltrate encompassing a previously patent vessel, elastin expression localized to the vessel remnants (Figure 1 , B′ and B′′), identifi ed on the basis of its elastic lamellae and α-smooth muscle actin (α-SMA) staining.
Increased smooth muscle and myofi broblasts in CBO
Elastic fi bers in the lung are largely the product of smooth muscle cells of blood vessels and conducting airways and myofi broblasts within alveolar walls. Sections of CBO lung, along with normal and emphysematous control lungs, were stained for α-SMA to determine whether altered abundance or distribution of cells expressing a "myo" phenotype may be responsible for the abnormal elastin expression found in this adult lung specimen (Figure 2) . The typical appearance and distribution of elastic fi bers and alveolar myofi broblasts in normal adult human lung is shown in Figure 2 , A and A′. Dense elastic fi bers localize to alveolar tips, where small alveolar myofi broblasts expressing α-SMA reside. In emphysematous lung specimens, some areas exhibit a loss of elastic fi bers associated with enlarged alveolar spaces, and the distribution of alveolar myofi broblasts is altered (Figure 2, B and B' ). In the CBO lung, alveolar regions had dense, enlarged elastic fi bers localizing to alveolar tips, where intensely staining myofi broblasts were found (Figure 2 , C and C'). In multiple sections containing areas of extensive remodeling in the CBO specimens, dense accumulations of disorganized elastic fi bers were populated by single cells and groups of cells staining intensely for α-SMA (Figure 2 , D/E and D'/E').
Discussion
In the case of cryptogenic CBO described, the root cause of the dyspnea and severe airways obstruction was suspected to be bronchiolitis, but the pathologic diagnosis was not confi rmed until after lung transplantation. Upon explantation of the diseased lung, it was observed that the lung did not defl ate, and that even sections of lung tissue removed for pathologic examination remained infl ated. These unusual fi ndings led to a more detailed analysis of the peripheral lung tissue, which was compared to other specimens from Figure 1 . Abnormal morphology, elastic fi ber accumulation, and elastin mRNA expression in CBO. Sections of peripheral lung tissue from CBO-affected lung (panels A and B), and control lung (panel C) were fi xed without infl ation, embedded, and sectioned at 5 μM. Serial sections were stained with H and E (A, B, C), for elastic fi bers using Hart's elastic fi ber stain (A′, B′, C′), and hybridized in situ for elastin mRNA (A″, B″, C″). In panel A, a large vessel (top of each panel) is fl anked by a large airway (bottom left of each panel) with accumulation of particulates, visible as black deposits, between the vessel and airway (indicated by white arrow in A and A′). A′ shows elastic laminae (stained black) in the intralobar pulmonary artery, and an increased density of elastic fi bers beneath the epithelium of the large airway and the surrounding lung parenchyma compared to control (C′). A″ shows that elastin mRNA expression (black signal) is present in the large blood vessel, conducting airway, and particularly in tissue between these structures, and is signifi cantly increased compared to control lung (C″). Panel B shows a large infi ltrate (top of panels) fl anked by surrounding tissue containing obliterated airways. Elastin staining in B′ indicates the infi ltrate likely encompasses an airway, as there is a continuous elastic fi ber (outlined by white dashed line) indicating a luminal structure has been present. Again, elastin density is increased compared to control lung (C'). B″ shows ongoing, intense elastin mRNA expression in tissue surrounding the infi ltrate that is greater than that seen in control lung (C″). an ongoing study of elastic fi ber changes in COPD. In marked contrast to emphysematous lungs, there was no evidence of alveolar septal destruction. In addition, alveolar elastic fi bers were greatly increased in number and density compared to normal lung specimens.
The role of elastic fi bers in CBO has not been well characterized. Pulmonary elastin is an extremely stable and long-lived polymer (Shapiro et al 1991) , and the majority of lung elastin expression is limited to the alveolar stage of lung development (Parks 1997; Mariani et al 2002) . Thus, in normal uninjured adult lungs, elastin expression is virtually non-existent. Even in lung pathology associated with extensive remodeling, fi brosis due to excess collagen deposition is much more common than elastosis. Notably, the remodeling of airway walls in CBO is thought to be the result of unrestrained collagenous fi brosis (Markopoulo et al 2002; Couture and Colby 2003; Visscher and Myers 2006) , a phenomenon that has been associated with and shown to be dependent upon increased transforming growth factorbeta (TGF-β) signaling (Ramirez et al 2004) . A number of other genes have been shown to undergo upregulation in response to TGF-β signalling, including elastin (Davidson et al 1995; Davidson 2002 ) and alpha smooth muscle actin (α-SMA) (Desmouliere et al 1993; Davidson 2002) . Most cell types expressing elastin in lung development, including airway and vascular smooth muscle cells and alveolar myofi broblasts, are positive for α-SMA, and upregulation of α-SMA has been implicated in the transition of cells to a myofi broblast phenotype in adults with idiopathic pulmonary fi brosis (Willis et al 2005) . For these reasons, we examined this case to characterize elastin mRNA expression and the abundance of α-SMA-positive cells.
The sampled lung showed evidence of severe CBO, with most of the areas demonstrating the phenomenon of 'disappearing' bronchioles, an indication of complete bronchiolar obliteration by the constrictive process. Elastic fi bers were abundant, dense, thick, and ropy in appearance in the affected bronchioles, and in situ hybridization for elastin mRNA showed abundant elastin expression localized to the collapsed and diseased bronchiolar walls, which were the primary sites of excess elastin accumulation. In addition, a similar upregulation of elastin deposition was noted in the adjacent alveolar areas, and was more extensive than those observed in either normal or emphysematous lung specimens.
The combination of upregulated elastin gene expression along with myofi broblast (α-SMA-positive cell) proliferation, when compared with normal lung, leads us to hypothesize that the elastosis noted in the bronchiolar and alveolar walls is likely the result of recent elastin protein synthesis. The specifi c signals leading to increased myofi broblast abundance and elastin expression are still unknown in this case.
